Memento Medicines
PrivateLast Round
Series A
Jun 18, 2026
Total Funding Raised
$93M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Memento Medicines is a biotechnology company developing biologic therapies for retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Memento Medicines Comparables
Compare Memento Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MabTics Co., Ltd. | 88% | |
| INGENIA Therapeutics | 83% | |
| AffaMed Therapeutics | 81% | |
Memento Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2026 |
Memento Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series A |
| RA Capital Management | Series A |
| Forbion | Series A |
| Sanofi Ventures | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$93M round led by RA Capital Management and Forbion.
Memento Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Memento Medicines's valuation, stock price, and market status.